berotek and metoprolol
berotek has been researched along with metoprolol in 25 studies
Research
Studies (25)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (64.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 1 (4.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Acevedo, O; Dasararaju, G; Devadasan, V; Halakova, D; Jayaprakash, V; Kovacikova, L; Mohd Siddique, MU; Mondal, SK; Prnova, MS; Shilkar, D; Stefek, M; Thakur, A; Yasmin, S | 1 |
| Boes, J; von Wichert, P | 1 |
| Becker, J; Hartung, HJ; Pohl, R; Wiest, W | 1 |
| Aschenbrenner, G; Blümel, G; Pfeiffer, U; Strigl, R | 1 |
| Anlauf, M; Bock, KD; Brodde, OE; Weber, F | 1 |
| Hötzinger, H; Schroll, A; Trenkwalder, U; Weidenbach, A; Wischnik, A; Wischnik, B | 1 |
| Hammerle, AF | 1 |
| Engelmann, A; Girndt, J; Grospietsch, G; Kuhn, U; Kuhn, W | 1 |
| Grogaard, J; Sundell, H | 1 |
| Heimisch, W; Mendler, N; Schroll, A; Weidenbach, A; Wieshammer, E; Wischnik, A; Wischnik, B | 1 |
| Heimisch, W; Mendler, N; Schroll, A; Weidenbach, A; Wischnik, A | 1 |
| Ulmer, WT; Zimmerman, I | 1 |
| von Wichert, P | 1 |
| Aschenbrenner, G; Birk, M; Blümel, G; Erhardt, W; Kohler, W; Pfeiffer, U; Sagerer, M; Strigl, R | 1 |
| Diemer, HP; Heidenreich, J; Poleska, W; Schmidt, H; Steyer, M | 1 |
| Irmer, M; Trolp, R | 1 |
| Bernius, U; Hillemanns, HG; Irmer, M; Pohl, C; Steim, H; Trolp, R | 1 |
| Ahmet, I; Heller, P; Krawczyk, M; Lakatta, EG; Moon, C; Talan, MI | 1 |
| Ahmet, I; Lakatta, EG; Talan, MI | 1 |
| Ahmet, I; Krawczyk, M; Lakatta, EG; Morrell, C; Poosala, S; Talan, MI; Woo, AY; Xiao, RP; Zhu, W | 1 |
| Baeyens, WR; De Beer, T; Dilinuer, M; Fei, GT; Ouyang, J; Wang, Y; Zhou, S | 1 |
Trials
3 trial(s) available for berotek and metoprolol
| Article | Year |
|---|---|
[Beta-receptor blocking drugs and the bronchial system. A comparative study of pindolol and metoprolol (author's transl)].
Topics: Bronchitis; Female; Fenoterol; Humans; Male; Metoprolol; Middle Aged; Pindolol; Plethysmography, Whole Body; Propanolamines | 1979 |
[Study on the influence of the beta-blocker metoprolol on flow resistance of airways in patients with chronic obstructive disease of airways (author's transl)].
Topics: Aged; Airway Obstruction; Airway Resistance; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Fenoterol; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Placebos; Propanolamines | 1980 |
Reversibility of bronchospasm in airway obstruction.
Topics: Airway Resistance; Bronchial Spasm; Bronchitis; Double-Blind Method; Female; Fenoterol; Humans; Male; Metoprolol; Middle Aged; Pindolol; Plethysmography, Whole Body; Propanolamines; Random Allocation | 1982 |
Other Studies
22 other study(ies) available for berotek and metoprolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
Topics: Aldehyde Reductase; Animals; Caco-2 Cells; Catalytic Domain; Dogs; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Madin Darby Canine Kidney Cells; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Protein Binding; Rats, Wistar; Structure-Activity Relationship; Thiazolidinediones | 2021 |
[Effect of subpartal tocolysis on maternal cardiovascular parameters with subsequent cesarean section in general anesthesia].
Topics: Adult; Anesthesia, General; Anesthesia, Obstetrical; Arrhythmias, Cardiac; Blood Pressure; Cesarean Section; Drug Therapy, Combination; Female; Fenoterol; Halothane; Heart Rate; Hemodynamics; Humans; Infusions, Parenteral; Intraoperative Complications; Metoprolol; Obstetric Labor, Premature; Pregnancy | 1986 |
Influence of the beta-1 selective blocker, metoprolol, on the development of pulmonary edema in tocolytic therapy.
Topics: Animals; Blood Pressure; Capillary Permeability; Cardiac Output; Dogs; Female; Fenoterol; Heart Rate; Humans; Metoprolol; Obstetric Labor, Premature; Pregnancy; Pulmonary Artery; Pulmonary Edema; Sympathomimetics; Vascular Resistance | 1986 |
Subclassification of human beta-adrenergic receptors mediating renin release.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Betaxolol; Dobutamine; Fenoterol; Humans; In Vitro Techniques; Isoproterenol; Male; Metoprolol; Propanolamines; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta; Renin | 1983 |
[The effect of the beta 1-blocker metoprolol on cyclic 3',5'-adenosine monophosphate in various tissues during long-term tocolysis with fenoterol. Animal experiments on the question of the interactive effects of the principal and adverse effects of beta 2
Topics: Adrenergic beta-Agonists; Animals; Cyclic AMP; Drug Therapy, Combination; Female; Fenoterol; Fetus; Heart Diseases; Lung; Metoprolol; Myocardium; Obstetric Labor, Premature; Pregnancy; Rats; Rats, Inbred Strains; Uterus | 1984 |
[New aspects in the therapy of pregnancy-induced hypertension].
Topics: Anesthesia, Epidural; Epoprostenol; Female; Fenoterol; Humans; Hypertension; Labetalol; Metoprolol; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Prostaglandins E; Ritodrine | 1983 |
[The effect of metoprolol on fenoterol-induced kidney function disorders].
Topics: Animals; Creatinine; Electrolytes; Ethanolamines; Female; Fenoterol; Hematocrit; Hemoglobins; Kidney Diseases; Metoprolol; Pulmonary Edema; Rabbits | 1983 |
Effect of beta-adrenergic agonists on apnea reflexes in newborn lambs.
Topics: Albuterol; Animals; Animals, Newborn; Apnea; Blood Circulation; Blood Pressure; Electric Stimulation; Fenoterol; Heart Rate; Laryngeal Nerves; Metoprolol; Propranolol; Reflex; Respiratory Center; Sheep; Terbutaline; Vascular Resistance | 1983 |
[Effect of the combination of the beta-1-blocker metoprolol with the tocolytic fenoterol on uteroplacental hemodynamics and fetal cardiovascular sensitivity with particular consideration of intrauterine fetal malnutrition. Results of animal experiments].
Topics: Animals; Ethanolamines; Female; Fenoterol; Fetus; Hemodynamics; Metoprolol; Oxytocin; Placenta; Placental Insufficiency; Pregnancy; Propanolamines; Regional Blood Flow; Sheep; Uterus | 1982 |
[The cardiac hazard of tocolysis and antagonising possibilities. I. The haemodynamic situation of the patient during tocolysis/Protection of the myocardium by means of cardioselective beta-blockade. Experimental results (author's transl)].
Topics: Animals; Blood Pressure; Cardiac Output; Coronary Vessels; Dogs; Ethanolamines; Female; Fenoterol; Heart Rate; Hemodynamics; Metoprolol; Myocardium; Obstetric Labor, Premature; Oxygen; Oxygen Consumption; Partial Pressure; Pregnancy | 1982 |
[Investigations in animal experiments into the influence of the beta-1-selective blocking agent metoprolol on the cardiovascular and metabolic side effects of the tocolytic fenoterol].
Topics: Animals; Blood Pressure; Dogs; Drug Interactions; Ethanolamines; Female; Fenoterol; Heart; Heart Rate; Metoprolol; Obstetric Labor, Premature; Oxygen; Partial Pressure; Pregnancy; Propanolamines | 1981 |
Combined use of beta-sympathomimetic drugs and beta-blockers during labour.
Topics: Atenolol; Blood Pressure; Ethanolamines; Female; Fenoterol; Heart Rate; Humans; Metoprolol; Obstetric Labor Complications; Pregnancy; Propanolamines; Tachycardia | 1981 |
[Tocolysis with a beta-receptor stimulating compound in patients with WPW-syndrome. A casuistic report (author's transl)].
Topics: Adult; Ethanolamines; Female; Fenoterol; Humans; Metoprolol; Obstetric Labor, Premature; Pregnancy; Tachycardia, Paroxysmal; Time Factors; Wolff-Parkinson-White Syndrome | 1980 |
[Efficency of tocoylsis by fenoterol and fenoterol in combination with a beta-1-blocking compound (author's transl)].
Topics: Drug Therapy, Combination; Ethanolamines; Female; Fenoterol; Heart Rate; Humans; Metoprolol; Obstetric Labor, Premature; Pregnancy; Propanolamines; Time Factors | 1980 |
Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Apoptosis; Cardiomyopathy, Dilated; Cell Size; Ethanolamines; Fenoterol; Male; Metoprolol; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Organ Size; Rats; Rats, Wistar; Signal Transduction; Ventricular Function, Left | 2004 |
Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Apoptosis; Blood Pressure; Cardiomyopathy, Dilated; Coronary Vessels; Disease Models, Animal; Drug Therapy, Combination; Fenoterol; Hypertrophy; Ligation; Male; Metoprolol; Myocardial Infarction; Myocardial Ischemia; Myocytes, Cardiac; Rats; Rats, Wistar; Stroke Volume; Ventricular Function, Left; Ventricular Remodeling | 2005 |
Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiac Volume; Cardiomyopathy, Dilated; Cardiotonic Agents; Drug Therapy, Combination; Electrocardiography; Fenoterol; Heart Ventricles; Male; Metoprolol; Myocardial Infarction; Myocytes, Cardiac; Rats; Rats, Wistar; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Ventricular Remodeling | 2008 |
Simultaneous separation of eight beta-adrenergic drugs using titanium dioxide nanoparticles as additive in capillary electrophoresis.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Atenolol; Buffers; Celiprolol; Clenbuterol; Electroosmosis; Electrophoresis, Capillary; Fenoterol; Hydrogen-Ion Concentration; Isoproterenol; Metal Nanoparticles; Metoprolol; Propranolol; Reproducibility of Results; Terbutaline; Titanium; Uncertainty | 2008 |